Delivery Order SPE2DB22D2206-SPE2DB23FJL67

Award Date 7/28/23
Potential Completion Date 8/18/23
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $3,978.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562199399 TESTOPEL 75 MG PELLETS 100S. The order was placed under an existing Prime Vendor contract vehicle and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by October 5, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's mission to provide...
The Defense Logistics Agency awarded a $15,912 delivery order to Amerisourcebergen Drug Corporation for TESTOPEL 75 MG PELLETS 100S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the specified pharmaceutical product to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Funding is being provided by DLA to support its medical supply chain requirements. No set aside designation or subcontractors were identified. This...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100 units of Testopel 75 mg pellets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three weeks concluding in early September. As a major supplier of pharmaceuticals to the Department of Defense, this order for testosterone replacement therapy supports DLA's provision of medical...
This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency awarded a $3,978 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOPEL 75 MG PELLETS 100S. The prime contractor will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of DLA programs. Amerisourcebergen, headquartered in Conshohocken, will self-perform this order without the use of major subcontractors. The Defense Logistics Agency manages the global supply chain for the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued up to $3,978.09, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to a location in Conshohocken, Pennsylvania. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a ceiling value of $11,934.27. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of September 13, 2024. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,978.09 firm fixed price order is for the supply of TESTOPEL 75 MG PELLETS 100S pharmaceutical products. The order has a completion date of January 24, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and related distribution services to the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program and appears to be...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FJL67
    Delivery Order

The Defense Logistics Agency awarded a $3,978 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561750220 TESTOPEL 75 MG PELLETS 100S. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and calls for the delivery of testosterone pellets to a facility in Conshohocken, Pennsylvania by August 18, 2023. DLA will provide funding for this order, which supports medical supply needs for Department of Defense programs. No set aside designation or subcontractors were identified.

Generated 12/15/23, 3:49 AM